With respect to IGF2BP2 deficiency in hematopoietic cells, following CRE treatment, IGF2BP2–/– mice reconstituted with WT bone marrow cells (WT →IGF2BP2–/–) exhibited asthma signs as severe as those in wild‐type mice (WT → WT). The gene discussed is IGF2BP2; the disease is asthma.